Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Amphastar Pharmaceuticals is up 8.2% since the beginning of the year, but at $28.63 per share, it is still trading 11.3% ...

Novavax (NVAX) closed at $8.97 in the latest trading session, marking a +2.51% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 0.01%. Meanwhile, the Dow ...

Context for Novavax after recent share performance Novavax (NVAX) has drawn fresh attention after a recent move in its share price, with the stock showing a 3.3% one day return alongside gains over ...

Medical groups sue to halt CDC vaccine advisory meeting and new child immunization guidelines under Health Secretary RFK Jr. Read more here.

Private equity firm expands healthcare focus. Inflexion, a leading European mid-market private equity firm, appointed John ...

Experts say ‘they’re just coming up with reasons’ as agency says application lacked ‘adequate and well controlled’ trial ...

The Swiss government must disclose contracts concluded with pharmaceutical companies for the procurement of Covid vaccines.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in ...

Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” ...

Officials are going after metal-containing ingredients, including aluminum adjuvants. Here’s why vaccines need them ...